H A Haenssle1, C Fink2, F Toberer2, J Winkler2, W Stolz3, T Deinlein4, R Hofmann-Wellenhof4, A Lallas5, S Emmert6, T Buhl7, M Zutt8, A Blum9, M S Abassi10, L Thomas11, I Tromme12, P Tschandl13, A Enk2, A Rosenberger14. 1. Department of Dermatology, University of Heidelberg, Heidelberg, Germany. Electronic address: Holger.Haenssle@med.uni-heidelberg.de. 2. Department of Dermatology, University of Heidelberg, Heidelberg, Germany. 3. Department of Dermatology, Allergology and Environmental Medicine II, Munich, Germany. 4. Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria. 5. First Department of Dermatology, Aristotle University, Thessaloniki, Greece. 6. Department of Dermatology, University of Rostock, Rostock, Germany. 7. Department of Dermatology, University of Göttingen, Göttingen, Germany. 8. Department of Dermatology and Allergology, Klinikum Bremen-Mitte, Bremen, Germany. 9. Office Based Clinic of Dermatology, Konstanz, Germany. 10. Faculty of Computer Science and Mathematics, University of Passau, Passau, Germany. 11. Department of Dermatology, Lyons Cancer Research Center, Lyon 1 University, Lyon, France. 12. Department of Dermatology, Université Catholique de Louvain, St Luc University Hospital, Brussels, Belgium. 13. Department of Dermatology, Medical University of Vienna, Vienna, Austria. 14. Department of Genetic Epidemiology, University of Goettingen, Goettingen, Germany.
Abstract
BACKGROUND: Convolutional neural networks (CNNs) efficiently differentiate skin lesions by image analysis. Studies comparing a market-approved CNN in a broad range of diagnoses to dermatologists working under less artificial conditions are lacking. MATERIALS AND METHODS: One hundred cases of pigmented/non-pigmented skin cancers and benign lesions were used for a two-level reader study in 96 dermatologists (level I: dermoscopy only; level II: clinical close-up images, dermoscopy, and textual information). Additionally, dermoscopic images were classified by a CNN approved for the European market as a medical device (Moleanalyzer Pro, FotoFinder Systems, Bad Birnbach, Germany). Primary endpoints were the sensitivity and specificity of the CNN's dichotomous classification in comparison with the dermatologists' management decisions. Secondary endpoints included the dermatologists' diagnostic decisions, their performance according to their level of experience, and the CNN's area under the curve (AUC) of receiver operating characteristics (ROC). RESULTS: The CNN revealed a sensitivity, specificity, and ROC AUC with corresponding 95% confidence intervals (CI) of 95.0% (95% CI 83.5% to 98.6%), 76.7% (95% CI 64.6% to 85.6%), and 0.918 (95% CI 0.866-0.970), respectively. In level I, the dermatologists' management decisions showed a mean sensitivity and specificity of 89.0% (95% CI 87.4% to 90.6%) and 80.7% (95% CI 78.8% to 82.6%). With level II information, the sensitivity significantly improved to 94.1% (95% CI 93.1% to 95.1%; P < 0.001), while the specificity remained unchanged at 80.4% (95% CI 78.4% to 82.4%; P = 0.97). When fixing the CNN's specificity at the mean specificity of the dermatologists' management decision in level II (80.4%), the CNN's sensitivity was almost equal to that of human raters, at 95% (95% CI 83.5% to 98.6%) versus 94.1% (95% CI 93.1% to 95.1%); P = 0.1. In contrast, dermatologists were outperformed by the CNN in their level I management decisions and level I and II diagnostic decisions. More experienced dermatologists frequently surpassed the CNN's performance. CONCLUSIONS: Under less artificial conditions and in a broader spectrum of diagnoses, the CNN and most dermatologists performed on the same level. Dermatologists are trained to integrate information from a range of sources rendering comparative studies that are solely based on one single case image inadequate.
BACKGROUND: Convolutional neural networks (CNNs) efficiently differentiate skin lesions by image analysis. Studies comparing a market-approved CNN in a broad range of diagnoses to dermatologists working under less artificial conditions are lacking. MATERIALS AND METHODS: One hundred cases of pigmented/non-pigmented skin cancers and benign lesions were used for a two-level reader study in 96 dermatologists (level I: dermoscopy only; level II: clinical close-up images, dermoscopy, and textual information). Additionally, dermoscopic images were classified by a CNN approved for the European market as a medical device (Moleanalyzer Pro, FotoFinder Systems, Bad Birnbach, Germany). Primary endpoints were the sensitivity and specificity of the CNN's dichotomous classification in comparison with the dermatologists' management decisions. Secondary endpoints included the dermatologists' diagnostic decisions, their performance according to their level of experience, and the CNN's area under the curve (AUC) of receiver operating characteristics (ROC). RESULTS: The CNN revealed a sensitivity, specificity, and ROC AUC with corresponding 95% confidence intervals (CI) of 95.0% (95% CI 83.5% to 98.6%), 76.7% (95% CI 64.6% to 85.6%), and 0.918 (95% CI 0.866-0.970), respectively. In level I, the dermatologists' management decisions showed a mean sensitivity and specificity of 89.0% (95% CI 87.4% to 90.6%) and 80.7% (95% CI 78.8% to 82.6%). With level II information, the sensitivity significantly improved to 94.1% (95% CI 93.1% to 95.1%; P < 0.001), while the specificity remained unchanged at 80.4% (95% CI 78.4% to 82.4%; P = 0.97). When fixing the CNN's specificity at the mean specificity of the dermatologists' management decision in level II (80.4%), the CNN's sensitivity was almost equal to that of human raters, at 95% (95% CI 83.5% to 98.6%) versus 94.1% (95% CI 93.1% to 95.1%); P = 0.1. In contrast, dermatologists were outperformed by the CNN in their level I management decisions and level I and II diagnostic decisions. More experienced dermatologists frequently surpassed the CNN's performance. CONCLUSIONS: Under less artificial conditions and in a broader spectrum of diagnoses, the CNN and most dermatologists performed on the same level. Dermatologists are trained to integrate information from a range of sources rendering comparative studies that are solely based on one single case image inadequate.
Authors: Andreas Kleppe; Ole-Johan Skrede; Sepp De Raedt; Knut Liestøl; David J Kerr; Håvard E Danielsen Journal: Nat Rev Cancer Date: 2021-01-29 Impact factor: 60.716
Authors: Claire M Felmingham; Nikki R Adler; Zongyuan Ge; Rachael L Morton; Monika Janda; Victoria J Mar Journal: Am J Clin Dermatol Date: 2021-03 Impact factor: 7.403
Authors: Marc Combalia; Noel Codella; Veronica Rotemberg; Cristina Carrera; Stephen Dusza; David Gutman; Brian Helba; Harald Kittler; Nicholas R Kurtansky; Konstantinos Liopyris; Michael A Marchetti; Sebastian Podlipnik; Susana Puig; Christoph Rinner; Philipp Tschandl; Jochen Weber; Allan Halpern; Josep Malvehy Journal: Lancet Digit Health Date: 2022-05
Authors: Achim Hekler; Jakob N Kather; Eva Krieghoff-Henning; Jochen S Utikal; Friedegund Meier; Frank F Gellrich; Julius Upmeier Zu Belzen; Lars French; Justin G Schlager; Kamran Ghoreschi; Tabea Wilhelm; Heinz Kutzner; Carola Berking; Markus V Heppt; Sebastian Haferkamp; Wiebke Sondermann; Dirk Schadendorf; Bastian Schilling; Benjamin Izar; Roman Maron; Max Schmitt; Stefan Fröhling; Daniel B Lipka; Titus J Brinker Journal: Front Med (Lausanne) Date: 2020-05-06
Authors: Albert T Young; Kristen Fernandez; Jacob Pfau; Rasika Reddy; Nhat Anh Cao; Max Y von Franque; Arjun Johal; Benjamin V Wu; Rachel R Wu; Jennifer Y Chen; Raj P Fadadu; Juan A Vasquez; Andrew Tam; Michael J Keiser; Maria L Wei Journal: NPJ Digit Med Date: 2021-01-21
Authors: Julia Höhn; Achim Hekler; Eva Krieghoff-Henning; Jakob Nikolas Kather; Jochen Sven Utikal; Friedegund Meier; Frank Friedrich Gellrich; Axel Hauschild; Lars French; Justin Gabriel Schlager; Kamran Ghoreschi; Tabea Wilhelm; Heinz Kutzner; Markus Heppt; Sebastian Haferkamp; Wiebke Sondermann; Dirk Schadendorf; Bastian Schilling; Roman C Maron; Max Schmitt; Tanja Jutzi; Stefan Fröhling; Daniel B Lipka; Titus Josef Brinker Journal: J Med Internet Res Date: 2021-07-02 Impact factor: 5.428